CD4 and neoplasm: Studies have shown that B cells can kill tumor cells by encouraging T cells to become activated during an immune response, thus inhibiting the progression of tumors, and newer studies have shown that CD4+ T cells can directly play an antitumor role by inhibiting the cancer cell cycle 42, 43.